Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil vs Remifentanil in EC-IC Bypass Surgery
NCT06091904Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2023
- Primary completion
- Nov 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of sufentanil in pain (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Intraoperative hypotension. Started Nov 2023; status: recruiting.
02
Drugs
sufentanil
03
Conditions
pain
Beyond the preview
Go deeper on NCT06091904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06091904.